VGXI is a leading contract manufacturer of DNA based pharmaceuticals with over 15 years of experience providing high quality cGMP products to clinical trials worldwide. The company’s production services include high purity plasmid DNA preparations for pre-clinical research, highly documented (HD) plasmid for use in GMP virus production and toxicology studies, and cGMP plasmid DNA for clinical through commercial supply. The VGXI manufacturing staff is comprised of experts in Process Development, Quality Control, Quality Assurance and Validation of plasmid-based biopharmaceuticals. Finally, VGXI has an outstanding track record of success in manufacturing challenging plasmid products and complying with multiple regulatory agencies.

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071